Hbsag Clearance Continues to Increase Post-Treatment in Patients with Hcv Hbv Coinfection Treated with Peginterferon Alfa-2a Plus Ribavirin: 1.5 Year Follow-Up

臨床醫學研究所LIU, CHUN-JENCHUN-JENLIUWU, SHUN-SHENGSHUN-SHENGWUCHAO, YOU- CHENYOU- CHENCHAOYANG, SIEN-SINGSIEN-SINGYANGLIN, CHIH-LINCHIH-LINLINKAO, JIA-HORNGJIA-HORNGKAOLIU, CHEN-HUACHEN-HUALIUCHEN, PEI-JERPEI-JERCHENCHEN, DING-SHINNDING-SHINNCHENCHUANG, WAN-LONGWAN-LONGCHUANGLEE, CHUAN-MOCHUAN-MOLEEYU, MING-LUNGMING-LUNGYULU, SHENG-NANSHENG-NANLU2010-06-292018-07-062010-06-292018-07-062009http://ntur.lib.ntu.edu.tw//handle/246246/186663en-USHbsag Clearance Continues to Increase Post-Treatment in Patients with Hcv Hbv Coinfection Treated with Peginterferon Alfa-2a Plus Ribavirin: 1.5 Year Follow-Up